|
|||||
|
|
Management of the side-effects of intravenous bisphosphonates: targeting the serum parathyroid hormone elevation. |
|
| Authors: | A Berruti M Tucci D Generali A Mosca M Ardine F Vana L Dogliotti |
| Affiliation: | 1 Oncologia Medica, Azienda Ospedaliera San Luigi, Orbassano, Italy 2 Breast Unit, Azienda Ospedaliera Istituti Ospitalieri, Cremona, Italy 3 Centro Oncologico Ematologico Subalpino, Azienda Ospedaliera Molinette Torino, Italy |
| Abstract: | In their recent review article, Tanvetyanon and Stiff [1] pointedout that hypocalcemia is a frequent side-effect of intravenousbisphosphonates. This adverse event is usually mild and exceptionallysymptomatic, with the principle risk factors being pre-existinghypovitaminosis D, previous parathyroid surgery and intestinalresections. A direct consequence of hypocalcemia |
| Keywords: | |
| 本文献已被 ScienceDirect Oxford 等数据库收录！ | |